Global Peptide Synthesis Market Report and Forecast 2024-2032

The global peptide synthesis market was valued at USD 511.4 million in 2023, driven by increasing demand for peptide therapeutics in research and development activities across the globe. The market size is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032 to achieve a value of USD 1090.8 million by 2032.

Peptide Synthesis: Introduction

Peptide synthesis is the chemical process of creating peptides, which are short chains of amino acids linked together by peptide bonds. Peptides play crucial roles in various biological processes and are often used in medical and biochemical research, drug development, and therapeutic applications. Peptide synthesis involves the stepwise assembly of amino acids in a specific order to produce a desired peptide sequence.

Peptide synthesis techniques can be broadly classified into two categories: chemical synthesis and biosynthesis. Chemical synthesis involves the chemical coupling of protected amino acids using various activating agents and coupling reagents. Biosynthesis, on the other hand, utilizes living organisms such as bacteria or yeast to produce peptides through the expression of recombinant DNA. Peptides synthesized through chemical methods find applications in various fields, including drug discovery, functional studies of proteins, vaccine development, and therapeutic agents themselves. The ability to design and synthesize peptides with specific amino acid sequences and modifications has greatly contributed to the understanding of biological processes and the development of novel therapeutic strategies.

Key Trends in the Global Peptide Synthesis Market

The peptide synthesis market has experienced significant growth in recent years, driven by various factors such as the increasing demand for peptides in research and development, drug discovery, and therapeutic applications. Several key trends have emerged within the peptide synthesis market:

• Growing Therapeutic Applications: Peptides have gained prominence as potential therapeutic agents due to their high specificity, low toxicity, and ability to target specific biological pathways. Peptide-based therapeutics are being developed for the treatment of various diseases, including cancer, metabolic disorders, cardiovascular diseases, and infectious diseases.
• Custom Peptide Synthesis Services: The demand for custom peptides with specific sequences and modifications has risen significantly. Researchers and pharmaceutical companies often require customized peptides for their experiments and drug development processes.
• Increased Use of Automated Synthesis Systems: Automation has played a vital role in enhancing the efficiency, speed, and reproducibility of peptide synthesis. Automated peptide synthesizers have become widely adopted in both academic and industrial settings. These systems enable high-throughput peptide synthesis, facilitate the synthesis of longer and more complex peptide sequences, and reduce human error.
• Solid-Phase Peptide Synthesis (SPPS) Dominance: Solid-phase peptide synthesis (SPPS) remains the preferred method for peptide synthesis due to its versatility, efficiency, and compatibility with various chemistries. SPPS allows for stepwise synthesis of peptides on a solid support, enabling purification and characterization of intermediates at each stage.
• Peptide Library Synthesis: Peptide libraries have gained prominence in drug discovery and development processes. These libraries consist of large collections of peptides with diverse sequences, allowing researchers to screen for potential drug candidates or identify peptide motifs that interact with specific targets.

Global Peptide Synthesis Market Segmentations

The market can be categorised into technology, products, end user and region.

Market Breakup by Technology

• Solid-Phase
• Liquid-Phase
• Hybrid
• Recombinant

Market Breakup by Products

• Equipment
• Reagents
• Consumables
• Other Product

Market Breakup by End user

• Pharmaceutical and Biotechnology Companies
• Contract Development and Manufacturing Organization (CDMO)
• Academic and Research Institutes

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Peptide Synthesis Market Overview

The peptide synthesis market has experienced significant growth in recent years, driven by various factors such as the increasing demand for peptides in research and development, drug discovery, and therapeutic applications. The peptide synthesis market is witnessing significant growth in emerging markets, particularly in Asia Pacific and Latin America. Geographically, North America and Europe have traditionally been the dominant regions in the peptide synthesis market, owing to the presence of well-established pharmaceutical and biotechnology industries. However, the market is witnessing rapid growth in Asia Pacific, driven by the increasing investments in research and development activities, growing healthcare infrastructure, and rising demand for peptide-based therapeutics in countries like China, India, and Japan. These regions are experiencing a rise in pharmaceutical and biotechnology industries, increased government investments in research and development, and growing awareness about the therapeutic potential of peptides. The expansion of market players' presence in these regions and strategic collaborations are driving market growth.

Key Players in the Peptide Synthesis Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in peptide synthesis market are as follows:

• AAPPTec
• Anaspec
• Bachem Holding AG
• Biotage
• CSBio Company Inc.
• CEM Corporation
• Gyros Protein Technologies AB
• Merck KGaA
• Biosynth Carbosynth (Vivitide)
• Thermo Fisher Scientific

The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.